Literature DB >> 3718932

Structural and mechanistic studies on the HeLa and chicken liver proteins that catalyze glycinamide ribonucleotide synthesis and formylation and aminoimidazole ribonucleotide synthesis.

S C Daubner, M Young, R D Sammons, L F Courtney, S J Benkovic.   

Abstract

Glycinamide ribonucleotide (GAR) transformylase from HeLa cells has been purified 200-fold to apparent homogeneity with a procedure using two affinity resins. The activities glycinamide ribonucleotide synthetase and aminoimidazole ribonucleotide synthetase were found to copurify with GAR transformylase. Glycinamide ribonucleotide synthetase and GAR transformylase were separable only after exposure to chymotrypsin. Antibodies raised to pure L1210 cell GAR transformylase were able to precipitate the glycinamide ribonucleotide transformylase and GAR synthetase activities from HeLa and L1210 cells both in their native and in their proteolytically shortened forms. The compound N-10-(bromoacetyl)-5,8-dideazafolate was found to inhibit formylation but to leave the ATP-requiring synthetase activities intact.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3718932     DOI: 10.1021/bi00358a033

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Chromosomal localization of the gene for the human trifunctional enzyme, methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase.

Authors:  R Rozen; D Barton; J Du; D W Hum; R E MacKenzie; U Francke
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

2.  Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations.

Authors:  D Schild; A J Brake; M C Kiefer; D Young; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.

Authors:  F Itoh; O Russello; H Akimoto; G P Beardsley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 4.  Structural biology of the purine biosynthetic pathway.

Authors:  Y Zhang; M Morar; S E Ealick
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

5.  Heterologous expression and purification of active human phosphoribosylglycinamide formyltransferase as a single domain.

Authors:  C C Kan; M R Gehring; B R Nodes; C A Janson; R J Almassy; Z Hostomska
Journal:  J Protein Chem       Date:  1992-10

6.  Evidence for a novel glycinamide ribonucleotide transformylase in Escherichia coli.

Authors:  P Nygaard; J M Smith
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

7.  Cloning and in vivo expression of the human GART gene using yeast artificial chromosomes.

Authors:  A Gnirke; T S Barnes; D Patterson; D Schild; T Featherstone; M V Olson
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.